207 related articles for article (PubMed ID: 15051739)
1. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
Cox CD; Tsikouris JP
J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
3. [New usage for an old drug: acetylcysteine for contrast-induced nephropathy].
Asher I; Hammerman A; Sthoeger Z
Harefuah; 2005 Sep; 144(9):642-6; 675. PubMed ID: 16218537
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology and prevention of contrast-induced acute renal failure].
Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
6. Can we prevent acute kidney injury?
Venkataraman R
Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
[TBL] [Abstract][Full Text] [Related]
7. Contrast nephropathy: review focusing on prevention.
Maeder M; Klein M; Fehr T; Rickli H
J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
[TBL] [Abstract][Full Text] [Related]
8. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography.
Schmidt P; Pang D; Nykamp D; Knowlton G; Jia H
Ann Pharmacother; 2007 Jan; 41(1):46-50. PubMed ID: 17190844
[TBL] [Abstract][Full Text] [Related]
11. Prevention of contrast-induced nephropathy: a critical review.
Van Praet JT; De Vriese AS
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy.
Pucelikova T; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
[TBL] [Abstract][Full Text] [Related]
13. Strategies to reduce the risk of contrast-induced nephropathy.
Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA; Tumlin J;
Am J Cardiol; 2006 Sep; 98(6A):59K-77K. PubMed ID: 16949381
[TBL] [Abstract][Full Text] [Related]
14. Strategies to prevent contrast nephropathy.
Oudemans-van Straaten HM
Minerva Cardioangiol; 2005 Oct; 53(5):445-63. PubMed ID: 16179886
[TBL] [Abstract][Full Text] [Related]
15. New pharmacological protocols to prevent or reduce contrast media nephropathy.
Briguori C; Airoldi F; Morici N; Colombo A
Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine in the prevention of contrast-induced nephropathy.
Fishbane S
Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
[TBL] [Abstract][Full Text] [Related]
17. Contrast agent--associated nephrotoxicity.
Briguori C; Tavano D; Colombo A
Prog Cardiovasc Dis; 2003; 45(6):493-503. PubMed ID: 12800130
[TBL] [Abstract][Full Text] [Related]
18. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of contrast-induced nephropathy and management of high-risk patients].
Marenzi G
G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
